Search Results

InterGard Woven collagen coated vascular prostheses are indicated for surgical repair, bypass, or replacement of arteries in the treatment of aneurysmal and occlusive disease of the thoracic and abdominal aorta, visceral arteries, and proximal peripheral arteries. Due to the low porosity of the grafts, these products are recommended for use in patients requiring heparinization prior to or during surgery.

InterGard Woven Collagen Coated Vascular Prostheses

This document is a 510(k) clearance letter from the FDA for a medical device called "InterGard Woven Collagen Coated Vascular Prostheses." It declares the device substantially equivalent to legally marketed predicate devices, but it does not contain any information about acceptance criteria, device performance studies, or clinical trial data.

Therefore, I cannot provide the requested information based on the input text. The document is strictly a regulatory clearance and does not delve into the technical validation of the device.

Ask a specific question about this device

InterGard woven vascular prostheses are indicated for surgical repair, bypass, or replacement of arteries in the treatment of aneurysmal and occlusive disease of the abdominal aorta, visceral arteries, and proximal peripheral arteries. Due to the low porosity of the grafts, these products are recommended for use in patients requiring heparinization prior to or during surgery.

InterGard™ Woven Collagen Coated Vascular Prostheses

The provided document is a 510(k) clearance letter from the FDA for the InterGard™ Woven Collagen Coated Vascular Prostheses. This document does not contain information on acceptance criteria, reported device performance, or any study details that would demonstrate the device meets acceptance criteria.

The letter primarily:

• Confirms that the device is substantially equivalent to legally marketed predicate devices.
• Outlines post-market surveillance study requirements under Section 522(a) of the act.
• Details device tracking requirements under Section 519(e) of the act.
• Provides general information on regulatory responsibilities.
• Includes an "Indications for Use" statement for the device.

Therefore, I cannot fulfill your request for:

1. A table of acceptance criteria and reported device performance.
2. Sample size used for the test set and data provenance.
3. Number and qualifications of experts for ground truth.
4. Adjudication method.
5. MRMC comparative effectiveness study details.
6. Standalone algorithm performance.
7. Type of ground truth used.
8. Sample size for the training set.
9. Ground truth establishment for the training set.

Ask a specific question about this device